ENTG heads into its July 30 earnings report having shed 16% in a week and 27% in a month, making Wednesday's print one of the most consequential in recent memory.
The stock closed at $118.16 on Tuesday, down 6.5% on the day alone. That one-day move is notable in isolation. In context, it is part of a broader semiconductor equipment rout: closest peer AMKR dropped 25% on the day and 32% on the week, FORM fell 10% and 22%, and LRCX slid 8% and 16%. KLAC, the most defensive of the group, still lost 6% on the day and 12% on the week. ENTG's 16% weekly decline sits roughly in the middle of this peer cluster — badly hurt, but not the epicentre.
The short-interest picture has shifted meaningfully heading into results. Bears have been covering, not pressing. Short interest dropped from roughly 8.4% of free float at the start of July to 6.0% now — a 15% week-on-week decline and 30% off the early-July peak near 12.8 million shares. That retreat suggests short sellers were positioned well ahead of this selloff and have been taking profits into the fall rather than adding exposure. The borrow market stays relaxed, reinforcing that read: availability runs at 678% — far above the 52-week floor of 256% — with cost to borrow at just 0.51%, barely above its recent lows. The ORTEX short score at 44.3 has declined over the past week, consistent with the story of shorts reducing rather than building. Squeeze risk is negligible; the shorts that matter already moved.
Options traders are modestly more cautious than usual, though not alarmed. The put/call ratio of 0.44 runs above its 20-day average of 0.38 by about 1.2 standard deviations — a mild defensive tilt. Relative to the 52-week range of 0.14 to 1.19, current readings are firmly in the lower half, meaning the options market is not pricing a dramatic event. For a stock down 27% in a month heading into earnings, that is an interesting gap.
The Street had been broadly constructive before this week's damage. Most recent analyst moves, dating from late June and early July, raised price targets: Mizuho lifted its target to $200, BMO Capital to $167, and Deutsche Bank to $155 — all maintaining existing ratings. The consensus mean target of $166 implies more than 40% upside from current levels, though those targets predate the latest leg down and may be revised on Wednesday's call. Goldman Sachs, the outlier, carries a Sell with a $95 target — below the current price — and has been bearish since at least early 2026. The bull case centres on purification solutions demand and margin expansion through the second half of 2026; the bear case points to 40% EBITDA flow-through and cyclical exposure as the semiconductor capex cycle cools. The valuation compression tells part of that story: the PE multiple has fallen 14 turns over the past 30 days to 27.7x, and EV/EBITDA has shed 1.6 turns to 19.8x.
Institutional holders were still adding in Q2. Capital Research increased its stake by 5.4 million shares to 7.5% of the company as of June 30. BlackRock added 1.5 million shares to reach 12.7%. Those are the most recent reported moves and predate the current drawdown, so they reflect conviction built at materially higher prices. Insider activity, last reported through early June, ran net positive on shares outstanding but consisted largely of routine equity awards offset by plan sales — no signal of unusual conviction in either direction.
Two prior earnings prints from the ORTEX data reinforce a cautious pattern: the May 2026 report produced a 1% next-day decline, and the April 2026 report a 4.7% fall. Both recovered partially over five days but remained lower than the pre-print close. The July 30 release — with the stock already deeply discounted and sector sentiment fractured — sets up a binary: either management reaffirms the H2 growth narrative and sparks a relief rally against a heavily sold backdrop, or guidance disappoints and finds a market with few remaining buyers. The gap between the current price of $118 and a consensus target still anchored near $166 makes Wednesday's conference call the sole lens worth watching.
See the live data behind this article on ORTEX.
Open ENTG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
